This is unpublished

H. Joachim

Physician & Research Faculty
Professor Emeritus, Clinical Research Division, Fred Hutchinson Cancer Center
Professor Emeritus, Division of Hematology and Oncology, University of Washington

Photo: Fred Hutch

Education and Training

  • M.D., Friedrich Wilhelms Universität, Bonn, Germany 
  • Internship and Residency, University of Bonn
  • Internship and Residency, University of Rochester 
  • Fellowship, UW 



Research and/or clinical career

Dr. Joachim Deeg is an expert in bone marrow failure and blood and bone marrow cancers. He is interested in how leukemia develops, especially via a precancerous blood disorder called myelodysplastic syndrome, or MDS. His research encompassed pathophysiology, genetics and gene regulation of this disorder and its progression to leukemia. He also led clinical trials of new treatment approaches for MDS. He has established bone marrow transplantation from healthy donors as a curative therapy for MDS, aplastic anemia and a group of blood cancers called myeloproliferative neoplasms. Dr. Deeg has also worked extensively in animal models and developed a regimen, adopted worldwide, for the prevention of graft-vs.-host disease, or GVHD, a common and potentially dangerous complication of blood stem cell transplantation. His studies have included the use of alpha-1 anti-trypsin to treat GVHD. Dr. Deeg is also interested in the ethics of decision-making regarding the optimal treatment strategy for a given patient.